Koseikai Takeda Hospital

Kyoto, Kyoto 600-8558

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer's Disease, Early Preclinical Alzheimer's Disease, Preclinical Alzheimer's Disease

Studies at this site

• AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid — Running, not enrolling
• A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia — Stopped early